King Andrew James
Chief Scientific Officer at CHINOOK THERAPEUTICS, INC.
- Sold, on record
- $1.1M
- Dollars the filings state
- Form 4 sales
- 13
- Latest Aug 1, 2023
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- CHINOOK THERAPEUTICS, INC.Chief Scientific Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale CHINOOK THERAPEUTICS, INC.UnusualJul 11, 2022 2022
Sold 5,000 shares at $18.09 ($90k)
King Andrew James, Chief Scientific Officer
Sold 45.9% of holdings ($197k position)5,897 shares left2x usual sizeFiling
- 2 Form 4 sale CHINOOK THERAPEUTICS, INC.UnusualAug 4, 2022 +24 days
Sold 5,000 shares at $20.00 ($100k)
King Andrew James, Chief Scientific Officer
Sold 45.9% of holdings ($218k position)5,897 shares left1.3x usual sizeFiling
- 3 Form 4 sale CHINOOK THERAPEUTICS, INC.Plan not statedOct 6, 2022 +63 days
Sold 3,557 shares at $19.69 ($70k)
King Andrew James, Chief Scientific Officer
Sold 22.2% of holdings ($316k position)12,492 shares left0.7x usual sizeFiling
- 4 Form 4 sale CHINOOK THERAPEUTICS, INC.UnusualJan 3, 2023 +89 days
Sold 10,000 shares at $25.82 ($258k)
King Andrew James, Chief Scientific Officer
Sold 50% of holdings ($516k position)9,992 shares left2.3x usual sizeFiling
- 5 Form 4 sale CHINOOK THERAPEUTICS, INC.Plan not statedJan 31, 2023 +28 days
Sold 3,244 shares at $24.68 ($80k)
King Andrew James, Chief Scientific Officer
Sold 17.7% of holdings ($452k position)15,081 shares left0.6x usual sizeFiling
- 6 Form 4 sale CHINOOK THERAPEUTICS, INC.Plan not statedFeb 10, 2023 +10 days
Sold 2,392 shares at $23.75 ($57k)
King Andrew James, Chief Scientific Officer
Sold 10.9% of holdings ($520k position)19,492 shares left0.6x usual sizeFiling
- 7 Form 4 sale CHINOOK THERAPEUTICS, INC.RoutineApr 3, 2023 +52 days
Sold 5,000 shares at $23.34 ($117k)
King Andrew James, Chief Scientific Officer
10b5-1 planSold 22.7% of holdings ($513k position)16,992 shares left1.4x usual sizeFiling
- 8 Form 4 sale CHINOOK THERAPEUTICS, INC.No planAug 1, 2023 +120 days
Sold 1,168 shares at $39.03 ($46k)
King Andrew James, Chief Scientific Officer
No 10b5-1 planSold 5.7% of holdings ($793k position)19,157 shares left0.3x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (13)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 1, 2023 | Aug 1, 2023 | CHINOOK THERAPEUTICS, INC. | Chief Scientific Officer | Form 4 sale | 1,168 | $46k | 5.7% | No plan | SEC |
| Apr 3, 2023 | Apr 5, 2023 | CHINOOK THERAPEUTICS, INC. | Chief Scientific Officer | Form 4 sale | 5,000 | $117k | 22.7% | Routine | SEC |
| Feb 10, 2023 | Feb 15, 2023 | CHINOOK THERAPEUTICS, INC. | Chief Scientific Officer | Form 4 sale | 2,392 | $57k | 10.9% | Plan not stated | SEC |
| Jan 31, 2023 | Feb 2, 2023 | CHINOOK THERAPEUTICS, INC. | Chief Scientific Officer | Form 4 sale | 3,244 | $80k | 17.7% | Plan not stated | SEC |
| Jan 3, 2023 | Jan 4, 2023 | CHINOOK THERAPEUTICS, INC. | Chief Scientific Officer | Form 4 sale | 10,000 | $258k | 50.0% | Unusual | SEC |
| Oct 6, 2022 | Oct 11, 2022 | CHINOOK THERAPEUTICS, INC. | Chief Scientific Officer | Form 4 sale | 3,557 | $70k | 22.2% | Plan not stated | SEC |
| Aug 4, 2022 | Aug 5, 2022 | CHINOOK THERAPEUTICS, INC. | Chief Scientific Officer | Form 4 sale | 5,000 | $100k | 45.9% | Unusual | SEC |
| Jul 11, 2022 | Jul 13, 2022 | CHINOOK THERAPEUTICS, INC. | Chief Scientific Officer | Form 4 sale | 5,000 | $90k | 45.9% | Unusual | SEC |
| Apr 11, 2022 | Apr 13, 2022 | CHINOOK THERAPEUTICS, INC. | Chief Scientific Officer | Form 4 sale | 5,000 | $77k | 45.9% | Unusual | SEC |
| Feb 18, 2022 | Feb 23, 2022 | CHINOOK THERAPEUTICS, INC. | Chief Scientific Officer | Form 4 sale | 2,500 | $33k | 29.8% | Unusual | SEC |
| Feb 11, 2022 | Feb 14, 2022 | CHINOOK THERAPEUTICS, INC. | Chief Scientific Officer | Form 4 sale | 2,498 | $32k | 22.9% | Plan not stated | SEC |
| Feb 10, 2022 | Feb 11, 2022 | CHINOOK THERAPEUTICS, INC. | Chief Scientific Officer | Form 4 sale | 2,500 | $33k | 37.9% | Unusual | SEC |
| Nov 9, 2021 | Nov 12, 2021 | CHINOOK THERAPEUTICS, INC. | Chief Scientific Officer | Form 4 sale | 5,000 | $68k | 55.0% | Unusual | SEC |